Pharmacists are encouraged to use K-TRACS to evaluate a patient’s prescription drug history prior to filling controlled substances.
However, K-TRACS should not be the sole determining factor in what type of prescription the patient receives or whether the patient receives one at all. Instead, K-TRACS should be part of the clinical decision-making process, used in combination with patient screenings and assessments.
K-TRACS provides tools that can be used in this capacity:
There are just a few guidelines for using K-TRACS to maintain patient confidentiality and gain efficiencies in your practice.
Learn how to add and manage delegates within K-TRACS to improve your workflow.
K-TRACS is connected to many other states to allow you to search for patient data from multiple states.
Learn how to manage duplicate listings for your patients in K-TRACS.
Risk indicator scores are intended to contribute to patient assessment and inform discussion of current treatment goals and appropriate risk mitigation strategies. Read additional information about risk indicator scores.
Overdose risk scores are different from risk indicator scores and specifically outline patient's risk for unintentional overdose death. Read additional information about overdose risk scores.